Lifetime cost-effectiveness simulation of once-weekly exenatide in type 2 diabetes: A cost-utility analysis based on the EXSCEL trial. (2022)
Attributed to:
Using big data to improve population health and resource allocation for people with diabetes in Malaysia
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.diabres.2021.109152
PubMed Identifier: 34813910
Publication URI: http://europepmc.org/abstract/MED/34813910
Type: Journal Article/Review
Volume: 183
Parent Publication: Diabetes research and clinical practice
ISSN: 0168-8227